News from transition therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Toronto:TTH,NASDAQ-NMS:TTHI)

Feb 09, 2016, 16:32 ET

Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results

TORONTO, Feb. 9, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...

Feb 05, 2016, 13:01 ET

Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST

TORONTO, Feb. 5, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...

Feb 01, 2016, 06:01 ET

Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401

TORONTO, Feb. 1, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...

Jan 06, 2016, 06:01 ET

Transition Therapeutics Announces Annual General Meeting Voting Results

TORONTO, Jan. 6, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announces that the...

Nov 19, 2015, 11:45 ET

Transition Therapeutics to Host Investor Day November 23 in New York

Live Webcast Beginning at 12 PM Eastern Time TORONTO, Nov. 19, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company")...

Nov 10, 2015, 16:01 ET

Transition Therapeutics Announces First Quarter Fiscal 2016 Financial Results

TORONTO, Nov. 10, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...

Nov 02, 2015, 06:01 ET

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST

TORONTO, Nov. 2, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...

Oct 29, 2015, 16:01 ET

Transition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug Candidate

TORONTO, Oct. 29, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...

Oct 28, 2015, 06:01 ET

Transition Therapeutics Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's Disease (CTAD) Conference

TORONTO, Oct. 28, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...

Oct 15, 2015, 06:01 ET

Transition Therapeutics Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression in Alzheimer's Disease Patients

- Primary efficacy endpoint not achieved in overall study - ELND005 significantly (p value < .05) improved agitation and aggression in...

Sep 15, 2015, 16:01 ET

Transition Therapeutics Announces Fiscal 2015 Financial Results

TORONTO, Sept. 15, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...

Sep 14, 2015, 06:01 ET

Transition Therapeutics to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. EST

TORONTO, Sept. 14, 2015 /CNW/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference call...

Aug 10, 2015, 16:01 ET

Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference

TORONTO, Aug. 10, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...

Jun 24, 2015, 06:01 ET

Transition Therapeutics Announces Results of Clinical Study of ELND005 in Agitation and Aggression in Patients with Alzheimer's Disease

TORONTO, June 24, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that a Phase...

Jun 16, 2015, 06:01 ET

Transition Therapeutics Appoints Carl Damiani as President

TORONTO, June 16, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) Chairman and Chief...

May 26, 2015, 06:01 ET

Transition Therapeutics to Present at the Jefferies 2015 Healthcare Conference

TORONTO, May 26, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that Dr....

May 12, 2015, 16:01 ET

Transition Therapeutics Announces Third Quarter Fiscal 2015 Financial Results

TORONTO, May 12, 2015 /PRNewswire/ -Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...

May 07, 2015, 16:01 ET

Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2015 Financial Results on Tuesday, May 12th, at 4:30 P.M. EST

TORONTO, May 7, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a...

May 06, 2015, 06:01 ET

Transition Therapeutics In-Licenses Phase 2 Drug Candidate from Lilly

TORONTO, May 6, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced its...

Mar 26, 2015, 06:01 ET

Transition Therapeutics Announces Results from Phase 1 AME & Renal Clearance Clinical Studies of Neuropsychiatric Drug Candidate ELND005

TORONTO, March 26, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced...